当前位置:首页 / 术前干眼治疗对白内障合并无症状干眼患者白内障术后 眼表指标、睑板腺功能及术后有症状干眼发生率的影响
论著·临床研究 | 更新时间:2023-09-21
|
术前干眼治疗对白内障合并无症状干眼患者白内障术后 眼表指标、睑板腺功能及术后有症状干眼发生率的影响
Effect of preoperative dry eye therapy on ocular surface indices, meibomian gland function, and the incidence rate of postoperative symptomatic dry eye in patients with cataract and concomitant asymptomatic dry eye after cataract surgery

广西医学 2023第45卷14期 页码:1685-1689

作者机构:刘兰静,硕士,主治医师,研究方向:白内障。

  • 中文简介
  • 英文简介
  • 参考文献
目的探讨术前干眼治疗对白内障合并无症状干眼患者白内障术后眼表指标、睑板腺功能及术后有症状干眼发生率的影响。方法将80例(80只眼)行白内障手术的白内障合并无症状干眼患者分为观察组和对照组,每组40例(40只眼)。术前2周,给予观察组患者干眼治疗,对照组则不做任何相关处理。比较两组患者术前2周(t1)、术前1 d(t2)、术后1周(t3)、术后1个月(t4)的眼表疾病指数(OSDI)量表评分、泪膜破裂时间(BUT)、泪液分泌试验(SIT),以及角膜荧光染色(CFS)阳性发生率、睑板腺功能异常发生率。记录两组患者t3、t4的有症状干眼及睑板腺功能障碍的发生情况。结果(1)与t1相比,观察组t2的OSDI量表评分降低,SIT结果及BUT均延长;与t2相比,两组t3、t4的OSDI量表评分均升高,SIT结果及BUT均缩短(均P<0.05)。观察组t3的OSDI量表评分低于对照组,t2、t3的BUT均长于对照组(均P<0.05)。(2) 观察组t2的睑板腺功能异常发生率低于t1,而t4的睑板腺功能异常发生率高于t2,且观察组t2、t3的睑板腺功能异常发生率均低于对照组(均P<0.05),而两组各时间点的CFS阳性发生率差异均无统计学意义(均P>0.05)。(3)观察组t4的有症状干眼发生率低于对照组,t3、t4的睑板腺功能障碍发生率均低于对照组(均P<0.05)。结论术前干眼治疗可以明显减轻白内障合并无症状干眼患者术后早期的干眼症状,改善泪膜稳定性,减少术后睑板腺功能障碍和有症状干眼的发生。
ObjectiveTo investigate the effect of preoperative dry eye therapy on ocular surface indices, meibomian gland function, and the incidence rate of postoperative symptomatic dry eye in patients with cataract and concomitant asymptomatic dry eye after cataract surgery. MethodsEighty patients (80 eyes) with cataract and concomitant asymptomatic dry eye who underwent cataract surgery were divided into observation group or control group, with 40 cases (40 eyes) in each group. Before 2 weeks of operation, the observation group received dry eye therapy, and the control group did not receive any treatment. The ocular surface disease index (OSDI) scale score, break-up time of tear film (BUT), Schirmer Ⅰ test (SIT), and positive incidence rate of corneal fluorescein staining (CFS), incidence rate of meibomian gland function abnormality at 2 weeks before operation (t1), 1 day before operation (t2), 1 week after operation (t3), and 1 month after operation (t4) were compared between patients of the two groups. The occurrence of symptomatic dry eye and meibomian gland dysfunction in patients of both groups was recorded at t3 and t4. Results(1) Compared with t1, the observation group yielded a decreased OSDI scale score at t2, and increased SIT result and BUT at t2; moreover, compared with t2, both groups exhibited an elevated OSDI scale score, and decreased SIT result and BUT at t3 and t4 (all P<0.05). The observation group interpreted a lower OSDI scale score as compared with the control group at t3, and longer BUT as compared with the control group at t2 and t3 (all P<0.05). (2) The observation group depicted a decreased incidence rate of meibomian gland function abnormality at t2 as compared with at t1, while the incidence rate of meibomian gland function abnormality at t4 was higher than that at t2, and the observation group yielded a lower incidence rate of meibomian gland function abnormality as compared with the control group at t2 and t3 (all P<0.05), whereas no statistically significant difference in CFS positive incidence rate was found between various time points (all P>0.05). (3) The observation group exhibited a lower incidence rate of symptomatic dry eye as compared with the control group at t4, and the incidence rate of meibomian gland dysfunction at t3 and t4 in the observation group was lower than that in the control group (all P<0.05). ConclusionPreoperative therapy for dry eye can prominently relieve early postoperative dry eye symptom in patients with cataract and concomitant asymptomatic dry eye, ameliorate the stability of tear film, and decrease the occurrence of postoperative meibomian gland dysfunction and symptomatic dry eye.

1411

浏览量

209

下载量

0

CSCD

工具集